Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Feigh

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
BMC Gastroenterology|February 2, 2024
Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias Flensted-Jensen, Denise Oró, Emma A Rørbeck, et al.
Scientific Reports|January 26, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisHelene M Ægidius, Sanne S Veidal, Michael Feigh, et al.
World Journal of Gastroenterology|January 30, 2018
INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisJonathan D Roth, Michael Feigh, Sanne S Veidal, et al.
Scientific Reports|December 28, 2023
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosisHenrik H Hansen, Susanne Pors, Maja W Andersen, et al.
Digestive Diseases and Sciences|December 5, 2018
Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisKirstine S Tølbøl, Birgit Stierstorfer, Jörg F Rippmann, et al.
Physiological Reports|September 23, 2025
Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosisJamal Bousamaki, Emma A Rørbeck, Asbjørn Graver Petersen, et al.
Scientific Reports|June 23, 2019
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHJonathan D Roth, Sanne S Veidal, Louise K D Fensholdt, et al.
Lipids|July 2, 2022
Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver diseaseJordon D Secor, Bennet S Cho, Lumeng J Yu, et al.
Basic & Clinical Pharmacology & Toxicology|March 13, 2026
Nintedanib Lacks Efficacy in a Spirometry-Confirmed and Bleomycin-Induced Mouse Model of Idiopathic Pulmonary FibrosisJamal Bousamaki, Grzegorz Maciag, Asbjørn Graver Petersen, et al.
Clinical and Translational Science|February 10, 2022
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
BMC Gastroenterology|February 2, 2024
Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias Flensted-Jensen, Denise Oró, Emma A Rørbeck, et al.
Scientific Reports|January 26, 2020
Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisHelene M Ægidius, Sanne S Veidal, Michael Feigh, et al.
World Journal of Gastroenterology|January 30, 2018
INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitisJonathan D Roth, Michael Feigh, Sanne S Veidal, et al.
Scientific Reports|December 28, 2023
Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosisHenrik H Hansen, Susanne Pors, Maja W Andersen, et al.
Digestive Diseases and Sciences|December 5, 2018
Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisKirstine S Tølbøl, Birgit Stierstorfer, Jörg F Rippmann, et al.
Physiological Reports|September 23, 2025
Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosisJamal Bousamaki, Emma A Rørbeck, Asbjørn Graver Petersen, et al.
Scientific Reports|June 23, 2019
Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHJonathan D Roth, Sanne S Veidal, Louise K D Fensholdt, et al.
Lipids|July 2, 2022
Structurally-engineered fatty acid 1024 (SEFA-1024) improves diet-induced obesity, insulin resistance, and fatty liver diseaseJordon D Secor, Bennet S Cho, Lumeng J Yu, et al.
Basic & Clinical Pharmacology & Toxicology|March 13, 2026
Nintedanib Lacks Efficacy in a Spirometry-Confirmed and Bleomycin-Induced Mouse Model of Idiopathic Pulmonary FibrosisJamal Bousamaki, Grzegorz Maciag, Asbjørn Graver Petersen, et al.
Clinical and Translational Science|February 10, 2022
Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASHMathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, et al.
Pageof 5